← All organizations

Evofem Inc.

For profitContributed to NMEWebsite ↗

Also known as: Evofem Inc. | EVOFEM INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 15, 2020

Timeline

2000s

Jan 1, 2009
Evofem Inc.— Founded

2010s

Sep 15, 2017
secnidazole— Marketing Organization
Jan 18, 2018
Neothetics, Inc— Acquired

2020s

May 22, 2020
lactic acid— NDA Secondary Org
May 22, 2020
potassium bitartrate— NDA Organization

Drugs by trial phase (9 distinct, 19 trials)

Phase 3 (4 own, 1 via acquisition)

Phase 2 (1 own, 3 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Neothetics, Inc

Recent trials (6)

NCT04553068Lead sponsorPhase 3Oct 15, 2020
NCT04553068Study directorPhase 3Oct 15, 2020
NCT03243305Lead sponsorPhase 3Jul 27, 2017
NCT03107377Lead sponsorPhase 2May 1, 2017
NCT02693418Lead sponsorPhase 1Aug 24, 2016
NCT01306331Lead sponsorPhase 3Apr 1, 2011

Details

Founded: San Diego, CA, US Jan 1, 2009
First NDA: May 22, 2020
Last known activity: Oct 15, 2020